| Name | PCSK9-IN-20 |
|---|
| Description | PCSK9-IN-20 (Compound 3i) is a PCSK9 inhibitor with an IC50 of 3.96 µM. PCSK9-IN-20 decreases PCSK9 and increases LDLR protein expression in vitro[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 3.96 µM (PCSK9)[1] |
| References |
| Molecular Formula | C27H32N6O5S2 |
|---|---|
| Molecular Weight | 584.71 |